Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Soner Altiok is active.

Publication


Featured researches published by Soner Altiok.


Current Opinion in Cell Biology | 1996

ADIPOCYTE DIFFERENTIATION : A TRANSCRIPTIONAL REGULATORY CASCADE

Regina P. Brun; Jae B. Kim; Erding Hu; Soner Altiok; Bruce M. Spiegelman

The adipose cell is now known to play a complex role in energy homeostasis, energy storage and signaling to other tissues concerning the state of energy balance. The past few years have seen an explosive increase in our knowledge of the transcriptional basis of adipocyte differentiation. Factors such as peroxisome proliferator-activated receptor gamma, the CCAAT/enhancer binding protein family members, and adipocyte determination- and differentiation-dependent factor 1 play important regulatory roles in this process. Furthermore, these factors provide a focus for beginning to understand how various hormones and metabolites influence the development of adipose tissue in vivo.


The EMBO Journal | 1997

Heregulin‐stimulated acetylcholine receptor gene expression in muscle: requirement for MAP kinase and evidence for a parallel inhibitory pathway independent of electrical activity

Nedret Altiok; Soner Altiok; Jean-Pierre Changeux

Binding of heregulin (HRG) to its receptor, ErbB3, results in a dimerization with ErbB2/neu and activation of their intrinsic tyrosine kinases, initiating a cascade of events resulting in the stimulation of acetylcholine receptor (AChR) genes in muscle. Here we have examined the signalling downstream of the HRG receptor. We show that phosphatidylinositol 3′‐kinase (PI3K) and SHC bind to the HRG‐activated ErbB3 in myotubes. Subsequently, p70S6 kinase (p70S6k), and MAP kinase ERK2 and thereby p90rsk are activated. However, inhibition of PI3K and p70S6k by wortmannin and rapamycin, respectively, failed to antagonize AChR α‐subunit gene expression stimulated by HRG, despite the fact that the activities of the kinases were inhibited. In contrast, these inhibitors elevated AChR α‐subunit mRNA levels, by themselves, independently of muscle electrical activity. On the other hand, the 17mer antisense oligonucleotide, EAS1, caused a specific depletion of ERK2 and eliminated the ability of HRG to stimulate AChR α‐subunit gene expression. These results indicate that HRG stimulates expression of AChR genes via ERK2 activation, and provide a physiological example of neurotrophic factor‐associated repression of AChR genes by stimulation of p70S6k activity which may contribute to the expression of adult type AChR genes at the neuromuscular junction.


Proceedings of the National Academy of Sciences of the United States of America | 1997

Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor γ and the retinoid X receptor

Peter Tontonoz; Samuel Singer; Barry M. Forman; Pasha Sarraf; Jonathan A. Fletcher; Christopher D. M. Fletcher; Regina P. Brun; Elisabetta Mueller; Soner Altiok; Heather Oppenheim; Ronald M. Evans; Bruce M. Spiegelman


Genes & Development | 1997

PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A.

Soner Altiok; Min Xu; Bruce M. Spiegelman


Archive | 1997

Methods and pharmaceutical compositions for inhibiting tumor cell growth

Bruce M. Spiegelman; Soner Altiok; Elisabetta Mueller; Pasha Sarraf; Peter Tontonoz


Archive | 1997

Methods and pharmaceutical compositions for inhibiting tumour cell growth

Bruce M. Spiegelman; Soner Altiok; Elisabetta Mueller; Pasha Sarraf; Peter Tontonoz


Archive | 1997

METHODEN UND PHARMAZEUTISCHE ZUSAMMENSTELLUNGEN ZUR WACHSTUMSVERHINDERUNG VON TUMORZELLEN ENTHALTEND EINEN PPAR-GAMMA AGONISTEN UND EINEN MAP KINASE INHIBITOR

Soner Altiok; Elisabetta Mueller; Pasha Serraf; M. Bruce Spiegelman; Peter Tontonoz


Archive | 1997

Procedes et compositions pharmaceutiques inhibant la proliferation de cellules tumorales

Bruce M. Spiegelman; Soner Altiok; Elisabetta Mueller; Pasha Sarraf; Peter Tontonoz


Archive | 1997

Methods and pharmaceutical compositions for inhibiting tumour cell growth comprising a ppar-gamma agonist and a map kinase inhibitor

Soner Altiok; Elisabetta Mueller; Pasha Serraf; Bruce M. Spiegelman; Peter Tontonoz


Archive | 1997

Methoden und pharmazeutische Zusammensetzungen zur Inhibition des Tumorwachstums Methods and pharmaceutical compositions for inhibiting tumor growth

Bruce M. Spiegelman; Soner Altiok; Elisabetta Mueller; Pasha Serraf; Peter Tontonoz

Collaboration


Dive into the Soner Altiok's collaboration.

Top Co-Authors

Avatar
Top Co-Authors

Avatar

Peter Tontonoz

Salk Institute for Biological Studies

View shared research outputs
Top Co-Authors

Avatar

Bruce M. Spiegelman

Texas Tech University Health Sciences Center

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Barry M. Forman

Salk Institute for Biological Studies

View shared research outputs
Researchain Logo
Decentralizing Knowledge